Nutex Health (NASDAQ:NUTX) Stock Price Down 3.8% – Here’s Why

Nutex Health Inc. (NASDAQ:NUTXGet Free Report) dropped 3.8% on Friday . The stock traded as low as $113.14 and last traded at $113.56. Approximately 28,904 shares changed hands during trading, a decline of 51% from the average daily volume of 59,506 shares. The stock had previously closed at $117.99.

Analysts Set New Price Targets

Separately, Maxim Group boosted their price target on Nutex Health from $75.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, April 8th.

Check Out Our Latest Stock Report on NUTX

Nutex Health Stock Performance

The stock’s 50-day moving average price is $83.95 and its 200 day moving average price is $53.48. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The company has a market cap of $633.67 million, a P/E ratio of -12.21 and a beta of 0.27.

Nutex Health (NASDAQ:NUTXGet Free Report) last announced its earnings results on Monday, March 31st. The company reported $11.12 EPS for the quarter, topping the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The firm had revenue of $81.30 million for the quarter, compared to the consensus estimate of $81.13 million.

Insider Buying and Selling at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of Nutex Health stock in a transaction dated Tuesday, April 8th. The stock was bought at an average cost of $81.81 per share, with a total value of $81,810.00. Following the completion of the transaction, the chief financial officer now owns 4,888 shares of the company’s stock, valued at $399,887.28. The trade was a 25.72 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 38.52% of the company’s stock.

Institutional Trading of Nutex Health

A number of hedge funds have recently bought and sold shares of the stock. State Street Corp acquired a new position in shares of Nutex Health during the third quarter valued at about $225,000. Drive Wealth Management LLC acquired a new position in Nutex Health in the 4th quarter valued at approximately $1,122,000. Baader Bank Aktiengesellschaft acquired a new position in Nutex Health in the 4th quarter valued at approximately $206,000. Legato Capital Management LLC lifted its position in shares of Nutex Health by 26.8% in the 4th quarter. Legato Capital Management LLC now owns 31,669 shares of the company’s stock worth $1,004,000 after acquiring an additional 6,697 shares during the period. Finally, Truist Financial Corp grew its holdings in shares of Nutex Health by 22.2% during the 4th quarter. Truist Financial Corp now owns 35,570 shares of the company’s stock worth $1,127,000 after purchasing an additional 6,454 shares in the last quarter. 5.32% of the stock is owned by institutional investors.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

See Also

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.